Here we go again...... Most penny OTC companies use pump and dump "IR" firms who get paid lots of restricted stock at a discount to put out bogus pumping reports. I don't see that here, do you? I see an individual analyst who has done reports for NASDAQ and NYSE traded companies in the bio/health fields, who got paid a small amount of money. He is also using market accepted formulas and principles for his estimates. Maybe when the company retains an investment banking firm, they will do a report too, but I am sure it will cost a LOT more than this one.
So the company "commissioning" a report for themselves is way better than a pump and dump "IR" firm doing so. Its positive - NOT NEGATIVE. I think this was a wise use of company funds instead of diluting shareholders.
News 
Market Data 
Discover 
